RecruitingNot Applicable

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

United States, Japan, South Korea20 participantsStarted 2022-05-11

Plain-language summary

To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Able to speak and read English, Spanish, Japanese or Korean
✓. Participants with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention
✓. Age ≥ 18

✕. Participants with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract
✕. Participants with known narcotic dependence, with average daily dose \> 5 mg oral morphine equivalent
✕. Participants deemed unable to comply with study and/or follow-up procedures, at investigators' discretion
✕. Participants who are pregnant (since are excluded from receiving standard-of-care MIPG or MITG)

(MDASI-GI) MD Anderson Symptom Inventory Questionnaire

Timeframe: 3 months after surgery

NCT IDNCT05205343

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-05-31

Naruhiko Ikoma, MD